(19)
(11) EP 3 242 671 A1

(12)

(43) Date of publication:
15.11.2017 Bulletin 2017/46

(21) Application number: 16735447.1

(22) Date of filing: 08.01.2016
(51) International Patent Classification (IPC): 
A61K 35/17(2015.01)
(86) International application number:
PCT/US2016/012573
(87) International publication number:
WO 2016/112245 (14.07.2016 Gazette 2016/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 08.01.2015 US 201562101181 P

(71) Applicant: Hackensack University Medical Center
Hackensack, NJ 07601 (US)

(72) Inventors:
  • ZILBERBERG, Jenny
    Yardley, PA 19067 (US)
  • LEE, Woo
    Lyndhurst, NJ 07071 (US)
  • KORNGOLD, Robert
    Wayne, NJ 07470 (US)

(74) Representative: J A Kemp 
14 South Square Gray's Inn
London WC1R 5JJ
London WC1R 5JJ (GB)

   


(54) EX VIVO METHODS FOR MINIMIZING RISKS AND MAXIMIZING BENEFITS OF ALLOGENEIC BLOOD AND MARROW TRANSPLANTATION